

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.46656934 |
| 2 | cellular response to type I interferon (GO:0071357) | 5.43741671 |
| 3 | type I interferon signaling pathway (GO:0060337) | 5.43741671 |
| 4 | response to type I interferon (GO:0034340) | 5.36954215 |
| 5 | positive regulation of type 2 immune response (GO:0002830) | 4.92965051 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 4.69748817 |
| 7 | regulation of chronic inflammatory response (GO:0002676) | 4.55689517 |
| 8 | regulation of T cell tolerance induction (GO:0002664) | 4.52034035 |
| 9 | regulation of interferon-alpha production (GO:0032647) | 4.43223434 |
| 10 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.36817435 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.30234539 |
| 12 | response to peptidoglycan (GO:0032494) | 4.22330894 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17095374 |
| 14 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 4.14874325 |
| 15 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.12032157 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.11074166 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08569158 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.00179913 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95951523 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.95951523 |
| 21 | regulation of tolerance induction (GO:0002643) | 3.95764759 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.89696609 |
| 23 | positive regulation of tolerance induction (GO:0002645) | 3.89640812 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.80293317 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.80293317 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.80293317 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.80293317 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.80293317 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.80293317 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.79684591 |
| 31 | negative regulation of viral genome replication (GO:0045071) | 3.79599304 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.77452681 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.76188308 |
| 34 | cellular response to interferon-alpha (GO:0035457) | 3.70948495 |
| 35 | response to interferon-beta (GO:0035456) | 3.70548621 |
| 36 | T cell migration (GO:0072678) | 3.70180010 |
| 37 | T-helper 1 type immune response (GO:0042088) | 3.69016776 |
| 38 | regulation of type 2 immune response (GO:0002828) | 3.66986841 |
| 39 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.66586039 |
| 40 | response to interferon-alpha (GO:0035455) | 3.64003751 |
| 41 | regulation of interleukin-12 production (GO:0032655) | 3.62415656 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.61579040 |
| 43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61002397 |
| 44 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.59765559 |
| 45 | defense response to protozoan (GO:0042832) | 3.53178391 |
| 46 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.52927936 |
| 47 | positive regulation of interleukin-12 production (GO:0032735) | 3.49587314 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46664658 |
| 49 | lymphocyte chemotaxis (GO:0048247) | 3.44015440 |
| 50 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.43772570 |
| 51 | myeloid dendritic cell differentiation (GO:0043011) | 3.43123378 |
| 52 | regulation of antigen processing and presentation (GO:0002577) | 3.42633776 |
| 53 | regulation of T-helper cell differentiation (GO:0045622) | 3.41515051 |
| 54 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.41410075 |
| 55 | cellular response to interferon-beta (GO:0035458) | 3.41221181 |
| 56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.39557058 |
| 57 | regulation of vitamin metabolic process (GO:0030656) | 3.39478050 |
| 58 | NIK/NF-kappaB signaling (GO:0038061) | 3.37560823 |
| 59 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.33240505 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32447006 |
| 61 | detection of other organism (GO:0098543) | 3.27952331 |
| 62 | * cellular response to interferon-gamma (GO:0071346) | 3.27875611 |
| 63 | positive regulation of interferon-beta production (GO:0032728) | 3.27537252 |
| 64 | response to protozoan (GO:0001562) | 3.26008381 |
| 65 | positive regulation of defense response to virus by host (GO:0002230) | 3.25454315 |
| 66 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.24569025 |
| 67 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.23306436 |
| 68 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.22994454 |
| 69 | * response to interferon-gamma (GO:0034341) | 3.22464871 |
| 70 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.17916947 |
| 71 | interferon-gamma secretion (GO:0072643) | 3.10218089 |
| 72 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.08853955 |
| 73 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08806199 |
| 74 | regulation of regulatory T cell differentiation (GO:0045589) | 3.06737798 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.06218349 |
| 76 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.05942076 |
| 77 | * defense response to virus (GO:0051607) | 3.03922351 |
| 78 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.03284949 |
| 79 | detection of external biotic stimulus (GO:0098581) | 3.02643438 |
| 80 | kynurenine metabolic process (GO:0070189) | 3.02273207 |
| 81 | B cell mediated immunity (GO:0019724) | 3.00962520 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 3.00861633 |
| 83 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.00722564 |
| 84 | myeloid dendritic cell activation (GO:0001773) | 2.99950661 |
| 85 | dendritic cell differentiation (GO:0097028) | 2.99329089 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97251250 |
| 87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97175100 |
| 88 | regulation of response to interferon-gamma (GO:0060330) | 2.96984688 |
| 89 | tryptophan catabolic process (GO:0006569) | 2.96828042 |
| 90 | indole-containing compound catabolic process (GO:0042436) | 2.96828042 |
| 91 | indolalkylamine catabolic process (GO:0046218) | 2.96828042 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 2.96030777 |
| 93 | detection of bacterium (GO:0016045) | 2.95051755 |
| 94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94547172 |
| 95 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.94265620 |
| 96 | regulation of interleukin-1 secretion (GO:0050704) | 2.93245471 |
| 97 | regulation of RIG-I signaling pathway (GO:0039535) | 2.92496493 |
| 98 | regulation of mononuclear cell migration (GO:0071675) | 2.92465064 |
| 99 | germinal center formation (GO:0002467) | 2.92172320 |
| 100 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.91880749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.15756406 |
| 2 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.97678489 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.28927549 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.85146223 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.58959809 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.14143820 |
| 7 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.72327308 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.62391814 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.60985985 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.27582946 |
| 11 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.01808885 |
| 12 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.98977506 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.97151971 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88091051 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64265235 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63238994 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59375710 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.39023804 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36496641 |
| 20 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27731510 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13451309 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.04737008 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98394449 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85068463 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.84931927 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64448068 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.61136662 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60240690 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59504018 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59324179 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58885447 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56630096 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55627746 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51574356 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50004987 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.45458436 |
| 37 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41635103 |
| 38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39387799 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37762888 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31449607 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31445440 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31113908 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29953453 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29286338 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26772721 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24546790 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22351146 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21804321 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16201108 |
| 50 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15612135 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12479409 |
| 52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10092080 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09557053 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06965947 |
| 55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04478513 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03965946 |
| 57 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02927322 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02599550 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02345559 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99192183 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99092187 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98128560 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97896257 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 0.97117982 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96630118 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88861939 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88593301 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88282719 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88002827 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87495662 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86598669 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85421394 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83959615 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83802767 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83770381 |
| 76 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82313192 |
| 77 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79764340 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.79186169 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77598948 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.77359361 |
| 81 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77234163 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76983421 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76692834 |
| 84 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73848733 |
| 85 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.72940915 |
| 86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.72277820 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.71639343 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.67309669 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66150036 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.65426050 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65421807 |
| 92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.64366878 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.64366878 |
| 94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.64025566 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.62906234 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61293505 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.60962096 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60457900 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.60270337 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.60059739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.80671322 |
| 2 | MP0003724_increased_susceptibility_to | 4.50750113 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.29749225 |
| 4 | MP0009785_altered_susceptibility_to | 3.84809786 |
| 5 | MP0006082_CNS_inflammation | 3.70735359 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.39603726 |
| 7 | MP0003436_decreased_susceptibility_to | 3.28735943 |
| 8 | MP0005671_abnormal_response_to | 3.07745046 |
| 9 | MP0001790_abnormal_immune_system | 3.03728632 |
| 10 | MP0005387_immune_system_phenotype | 3.03728632 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.95624027 |
| 12 | MP0005025_abnormal_response_to | 2.82673374 |
| 13 | MP0000685_abnormal_immune_system | 2.75388896 |
| 14 | MP0001800_abnormal_humoral_immune | 2.67427834 |
| 15 | MP0002419_abnormal_innate_immunity | 2.56093057 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.48606548 |
| 17 | MP0002723_abnormal_immune_serum | 2.47115674 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.45119337 |
| 19 | MP0004510_myositis | 2.31495555 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.16545255 |
| 21 | MP0009764_decreased_sensitivity_to | 2.12830333 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.12672670 |
| 23 | MP0004947_skin_inflammation | 2.09528114 |
| 24 | MP0001819_abnormal_immune_cell | 2.03586730 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.00860557 |
| 26 | MP0005451_abnormal_body_composition | 1.98678545 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.94790855 |
| 28 | MP0003448_altered_tumor_morphology | 1.75021802 |
| 29 | MP0008469_abnormal_protein_level | 1.73726582 |
| 30 | MP0003075_altered_response_to | 1.73117890 |
| 31 | MP0002405_respiratory_system_inflammati | 1.69347346 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.68488769 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.61447028 |
| 34 | MP0000343_altered_response_to | 1.56389655 |
| 35 | MP0005310_abnormal_salivary_gland | 1.55998316 |
| 36 | MP0006054_spinal_hemorrhage | 1.53398902 |
| 37 | MP0000716_abnormal_immune_system | 1.50011226 |
| 38 | MP0001853_heart_inflammation | 1.44816877 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.43419168 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.42877095 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.42841329 |
| 42 | MP0008004_abnormal_stomach_pH | 1.42734544 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.41123164 |
| 44 | MP0000858_altered_metastatic_potential | 1.39443095 |
| 45 | MP0002254_reproductive_system_inflammat | 1.38857197 |
| 46 | MP0005166_decreased_susceptibility_to | 1.36184229 |
| 47 | MP0000604_amyloidosis | 1.34079465 |
| 48 | MP0002398_abnormal_bone_marrow | 1.31924524 |
| 49 | MP0003195_calcinosis | 1.31087709 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.28964648 |
| 51 | MP0005164_abnormal_response_to | 1.28681237 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.27782203 |
| 53 | MP0009840_abnormal_foam_cell | 1.27126654 |
| 54 | MP0009278_abnormal_bone_marrow | 1.23126784 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.21885435 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.16322285 |
| 57 | MP0008260_abnormal_autophagy | 1.16313737 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.15859007 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.15859007 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.14655379 |
| 61 | MP0002429_abnormal_blood_cell | 1.12213698 |
| 62 | MP0004883_abnormal_blood_vessel | 1.12001301 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.10591774 |
| 64 | MP0009763_increased_sensitivity_to | 1.10564330 |
| 65 | MP0003690_abnormal_glial_cell | 1.07566111 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.07197362 |
| 67 | MP0002006_tumorigenesis | 1.05344092 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.02514388 |
| 69 | MP0002722_abnormal_immune_system | 1.02247878 |
| 70 | MP0005390_skeleton_phenotype | 0.99369741 |
| 71 | MP0003091_abnormal_cell_migration | 0.97565950 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.96250470 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.92239786 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.91420004 |
| 75 | MP0003866_abnormal_defecation | 0.88556100 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.83348469 |
| 77 | MP0002933_joint_inflammation | 0.81551643 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 0.79751647 |
| 79 | MP0001542_abnormal_bone_strength | 0.79117332 |
| 80 | MP0001873_stomach_inflammation | 0.78653956 |
| 81 | MP0001663_abnormal_digestive_system | 0.78064098 |
| 82 | MP0005023_abnormal_wound_healing | 0.76281770 |
| 83 | MP0003045_fibrosis | 0.75818635 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72606399 |
| 85 | MP0003828_pulmonary_edema | 0.70848803 |
| 86 | MP0000249_abnormal_blood_vessel | 0.70840916 |
| 87 | MP0001851_eye_inflammation | 0.69869588 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.69202527 |
| 89 | MP0008874_decreased_physiological_sensi | 0.69119996 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.67901650 |
| 91 | MP0005165_increased_susceptibility_to | 0.67769293 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.67191271 |
| 93 | MP0003795_abnormal_bone_structure | 0.66162330 |
| 94 | MP0000920_abnormal_myelination | 0.65288387 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.64678970 |
| 96 | MP0003646_muscle_fatigue | 0.62982358 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.62279516 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.60130919 |
| 99 | MP0001501_abnormal_sleep_pattern | 0.56080598 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.55959994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Optic neuritis (HP:0100653) | 6.19887378 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 6.19887378 |
| 3 | Orchitis (HP:0100796) | 6.05408106 |
| 4 | Myositis (HP:0100614) | 5.43442060 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.80623839 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.75657154 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.54379242 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 4.38201890 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.31372606 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.23105284 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.23105284 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.23105284 |
| 13 | Stomatitis (HP:0010280) | 4.22397658 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.19677023 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.18831449 |
| 16 | Keratoconjunctivitis (HP:0001096) | 4.05376803 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93488642 |
| 18 | Increased IgM level (HP:0003496) | 3.89621695 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.80402107 |
| 20 | Pulmonary infiltrates (HP:0002113) | 3.71138978 |
| 21 | Hemoptysis (HP:0002105) | 3.68884043 |
| 22 | Vasculitis (HP:0002633) | 3.65658054 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.46876276 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.44376555 |
| 25 | T lymphocytopenia (HP:0005403) | 3.41290706 |
| 26 | Recurrent skin infections (HP:0001581) | 3.38473553 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.35386308 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.32765023 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.32765023 |
| 30 | Gangrene (HP:0100758) | 3.30454687 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 3.26345259 |
| 32 | Recurrent viral infections (HP:0004429) | 3.23336787 |
| 33 | Arterial thrombosis (HP:0004420) | 3.15453420 |
| 34 | Encephalitis (HP:0002383) | 3.14355202 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 3.11221778 |
| 36 | Hypergammaglobulinemia (HP:0010702) | 3.01261088 |
| 37 | Peritonitis (HP:0002586) | 3.00198332 |
| 38 | Loss of speech (HP:0002371) | 2.93573372 |
| 39 | Meningitis (HP:0001287) | 2.85361902 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.84201230 |
| 41 | Chronic otitis media (HP:0000389) | 2.80701649 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80565458 |
| 43 | Leukocytosis (HP:0001974) | 2.76814050 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.73280877 |
| 45 | Gingivitis (HP:0000230) | 2.72836005 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.72433672 |
| 47 | Anorexia (HP:0002039) | 2.69417581 |
| 48 | Hematochezia (HP:0002573) | 2.66479851 |
| 49 | Vacuolated lymphocytes (HP:0001922) | 2.64568651 |
| 50 | Amyloidosis (HP:0011034) | 2.55465732 |
| 51 | Abnormality of the pleura (HP:0002103) | 2.53263558 |
| 52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.52846126 |
| 53 | Obstructive lung disease (HP:0006536) | 2.51343529 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51343529 |
| 55 | Nasal polyposis (HP:0100582) | 2.49202503 |
| 56 | Pulmonary embolism (HP:0002204) | 2.48603306 |
| 57 | Abnormality of the nasal mucosa (HP:0000433) | 2.43026657 |
| 58 | Chest pain (HP:0100749) | 2.42057795 |
| 59 | Increased IgE level (HP:0003212) | 2.41776458 |
| 60 | Glomerulonephritis (HP:0000099) | 2.41050717 |
| 61 | Disinhibition (HP:0000734) | 2.40886386 |
| 62 | Joint swelling (HP:0001386) | 2.39901340 |
| 63 | Urticaria (HP:0001025) | 2.39150013 |
| 64 | Abnormality of the endocardium (HP:0004306) | 2.37888337 |
| 65 | Abnormality of the pericardium (HP:0001697) | 2.36994716 |
| 66 | Polyneuropathy (HP:0001271) | 2.33193231 |
| 67 | Eosinophilia (HP:0001880) | 2.31410941 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.30205257 |
| 69 | Malnutrition (HP:0004395) | 2.24469112 |
| 70 | Abnormality of T cells (HP:0002843) | 2.23480791 |
| 71 | Glomerulopathy (HP:0100820) | 2.21896611 |
| 72 | Episodic fever (HP:0001954) | 2.21444199 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19292210 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19292210 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19292210 |
| 76 | Vertigo (HP:0002321) | 2.18634454 |
| 77 | Keratitis (HP:0000491) | 2.18380867 |
| 78 | Acne (HP:0001061) | 2.15736437 |
| 79 | Premature loss of primary teeth (HP:0006323) | 2.13787651 |
| 80 | Colitis (HP:0002583) | 2.13279220 |
| 81 | Myocardial infarction (HP:0001658) | 2.12914081 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.12468067 |
| 83 | Mucopolysacchariduria (HP:0008155) | 2.11890114 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11890114 |
| 85 | Purpura (HP:0000979) | 2.10694982 |
| 86 | Gingival bleeding (HP:0000225) | 2.10522903 |
| 87 | Basal ganglia calcification (HP:0002135) | 2.07936993 |
| 88 | Granulocytopenia (HP:0001913) | 2.07149131 |
| 89 | Increased serum ferritin (HP:0003281) | 2.06008574 |
| 90 | Parakeratosis (HP:0001036) | 2.03447287 |
| 91 | Progressive neurologic deterioration (HP:0002344) | 2.03319570 |
| 92 | Amaurosis fugax (HP:0100576) | 2.02445746 |
| 93 | Abnormality of the peritoneum (HP:0002585) | 2.01206900 |
| 94 | Arthralgia (HP:0002829) | 1.99793100 |
| 95 | Spontaneous hematomas (HP:0007420) | 1.98294914 |
| 96 | Thoracolumbar scoliosis (HP:0002944) | 1.96520053 |
| 97 | Complement deficiency (HP:0004431) | 1.95761687 |
| 98 | Alveolar cell carcinoma (HP:0006519) | 1.95692749 |
| 99 | Abnormality of eosinophils (HP:0001879) | 1.93490807 |
| 100 | IgA deficiency (HP:0002720) | 1.91410778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 4.77331417 |
| 2 | IRAK3 | 3.49380215 |
| 3 | MAP3K14 | 3.27899502 |
| 4 | IKBKE | 3.26815135 |
| 5 | JAK3 | 3.05322925 |
| 6 | GRK7 | 3.02752348 |
| 7 | FGFR4 | 2.94677331 |
| 8 | TXK | 2.92631648 |
| 9 | RIPK4 | 2.80975650 |
| 10 | JAK1 | 2.76335525 |
| 11 | TBK1 | 2.57164051 |
| 12 | MAP4K1 | 2.57160635 |
| 13 | IRAK4 | 2.50175427 |
| 14 | RIPK1 | 2.43285440 |
| 15 | BLK | 2.23353378 |
| 16 | MATK | 2.21981104 |
| 17 | CSK | 2.17068172 |
| 18 | PRPF4B | 2.06653852 |
| 19 | DDR2 | 2.00069171 |
| 20 | KIT | 1.99534850 |
| 21 | IKBKB | 1.88227572 |
| 22 | TAOK2 | 1.83584951 |
| 23 | FGFR3 | 1.80720817 |
| 24 | ERN1 | 1.73605579 |
| 25 | FGR | 1.66940776 |
| 26 | BMPR2 | 1.65875208 |
| 27 | ZAP70 | 1.60985319 |
| 28 | MAP3K3 | 1.47635417 |
| 29 | JAK2 | 1.45162459 |
| 30 | CDC42BPA | 1.39931043 |
| 31 | EPHA3 | 1.38778254 |
| 32 | ADRBK2 | 1.35548697 |
| 33 | IRAK1 | 1.33685408 |
| 34 | MAP2K3 | 1.26039757 |
| 35 | EPHB1 | 1.19153059 |
| 36 | TAOK1 | 1.15857350 |
| 37 | SYK | 1.15091026 |
| 38 | LYN | 1.12777543 |
| 39 | MAP3K11 | 1.10104560 |
| 40 | MAP3K13 | 1.08323472 |
| 41 | TGFBR2 | 1.07739931 |
| 42 | CHUK | 1.05404644 |
| 43 | LCK | 1.01690910 |
| 44 | HCK | 0.99958766 |
| 45 | MOS | 0.98293735 |
| 46 | PIM2 | 0.97949744 |
| 47 | BTK | 0.94489610 |
| 48 | MAP3K1 | 0.91243198 |
| 49 | SIK3 | 0.87687122 |
| 50 | TAOK3 | 0.80942053 |
| 51 | IRAK2 | 0.80529294 |
| 52 | NME2 | 0.80067415 |
| 53 | FES | 0.80003509 |
| 54 | HIPK2 | 0.73479482 |
| 55 | MAP3K5 | 0.73476024 |
| 56 | STK10 | 0.71806698 |
| 57 | CSF1R | 0.67140839 |
| 58 | TYRO3 | 0.65672878 |
| 59 | TNK2 | 0.61070496 |
| 60 | MAPK11 | 0.60399024 |
| 61 | ITK | 0.60350559 |
| 62 | CLK1 | 0.59802746 |
| 63 | NLK | 0.57538893 |
| 64 | TESK2 | 0.55852976 |
| 65 | MARK3 | 0.52277422 |
| 66 | PIM1 | 0.49703733 |
| 67 | TEC | 0.48376267 |
| 68 | EGFR | 0.38961258 |
| 69 | MAP2K6 | 0.37190925 |
| 70 | PDGFRA | 0.37186659 |
| 71 | DYRK3 | 0.37109583 |
| 72 | ACVR1B | 0.36981531 |
| 73 | MAPK7 | 0.36793903 |
| 74 | PDGFRB | 0.35686732 |
| 75 | CDK6 | 0.33961155 |
| 76 | PDK1 | 0.33410375 |
| 77 | ABL1 | 0.31735894 |
| 78 | MAPKAPK2 | 0.30515442 |
| 79 | FYN | 0.30324261 |
| 80 | PRKCD | 0.29674364 |
| 81 | GRK6 | 0.25137852 |
| 82 | STK24 | 0.24859197 |
| 83 | BMX | 0.24657272 |
| 84 | AKT3 | 0.24458304 |
| 85 | INSR | 0.24099774 |
| 86 | PRKCQ | 0.23472541 |
| 87 | MAPK4 | 0.23118776 |
| 88 | PDPK1 | 0.22877991 |
| 89 | EIF2AK2 | 0.22407574 |
| 90 | CDK4 | 0.22203349 |
| 91 | YES1 | 0.21377300 |
| 92 | MAP3K6 | 0.20302884 |
| 93 | RPS6KA5 | 0.19715644 |
| 94 | PKN1 | 0.19289066 |
| 95 | NEK9 | 0.19185822 |
| 96 | SGK3 | 0.18615007 |
| 97 | PIK3CG | 0.18052608 |
| 98 | KSR2 | 0.17237275 |
| 99 | DAPK2 | 0.17005018 |
| 100 | LRRK2 | 0.16412061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.36009405 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.16073269 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.86497803 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.79362908 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.77052760 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64616777 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.62003513 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58324615 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.56912345 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52996113 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.49933334 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39566985 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.28767910 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.28404400 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18522814 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 2.14827761 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.10605032 |
| 18 | Measles_Homo sapiens_hsa05162 | 2.10040723 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.09150858 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04956311 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.02086444 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.96196191 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.95071304 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85792667 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.79880899 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79524586 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.77263211 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.67858732 |
| 29 | Hepatitis C_Homo sapiens_hsa05160 | 1.58968598 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.58246280 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.57385809 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56753413 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50233954 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46810538 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45202720 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41273183 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31388653 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26397212 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.25857378 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.24288574 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.23346249 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09019489 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.08817433 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 0.97931131 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.96183503 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94798415 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91666667 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88597767 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87617527 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85920143 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85316563 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83699709 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.78794617 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78570293 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77206911 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77098124 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70294298 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66463577 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.65189216 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59724239 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53515436 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.51127928 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49664048 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49334370 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45134534 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43730995 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42108393 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40033068 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36248718 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35894472 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34110971 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33774685 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33643698 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33553389 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33210280 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32670597 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32588420 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31952838 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.30801604 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.29394407 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27173152 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27142804 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26140462 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25923072 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.21882618 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18073928 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16269529 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16021426 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.15067391 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.14467064 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12329065 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11881519 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.11104528 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.10078818 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.09661316 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.09551971 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.08924393 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06323363 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05827839 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.03919660 |

